Say you have been asked to design an experiment to complete a pharmacokinetic profile of a new antidepressant drug, How would you go about deciding what doses to use for (Oral / IV) administration in an in-vivo animal model using rats for example? Providing you have no toxicology information, would you use dosages that have been used in other anti-depressant studies? or is there a general rule for minimum / maximum doses being used for PK studies?

More Jake Ellis-Williams's questions See All
Similar questions and discussions